Virtus Investment [VRTS] vs BlackRock Science [BSTZ] Detailed Stock Comparison
Virtus Investment
NYSE
Loading...
BlackRock Science
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Virtus Investment wins in 6 metrics, BlackRock Science wins in 7 metrics, with 0 ties. BlackRock Science appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Virtus Investment | BlackRock Science | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 9.91 | 3.67 | BlackRock Science |
| Price-to-Book Ratio | 1.29 | N/A | N/A |
| Debt-to-Equity Ratio | 29.88 | 0.00 | BlackRock Science |
| PEG Ratio | 5.54 | N/A | N/A |
| EV/EBITDA | 5.47 | N/A | N/A |
| Profit Margin (TTM) | 13.35% | 0.00% | Virtus Investment |
| Operating Margin (TTM) | 16.79% | 0.00% | Virtus Investment |
| EBITDA Margin (TTM) | 16.79% | N/A | N/A |
| Return on Equity | 14.21% | 16.27% | BlackRock Science |
| Return on Assets (TTM) | 3.14% | 16.03% | BlackRock Science |
| Free Cash Flow (TTM) | $-3.82M | $231.70M | BlackRock Science |
| Dividend Yield | 4.97% | N/A | N/A |
| 1-Year Return | -6.81% | 18.90% | BlackRock Science |
| Price-to-Sales Ratio (TTM) | 1.28 | 5.72 | Virtus Investment |
| Enterprise Value | $1.36B | $0 | Virtus Investment |
| EV/Revenue Ratio | 1.51 | 0.00 | BlackRock Science |
| Gross Profit Margin (TTM) | 49.69% | N/A | N/A |
| Revenue per Share (TTM) | $128 | $4 | Virtus Investment |
| Earnings per Share (Diluted) | $16.85 | $6.22 | Virtus Investment |
| Beta (Stock Volatility) | 1.47 | N/A | N/A |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Virtus Investment vs BlackRock Science Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Virtus Investment | -5.05% | 3.14% | -0.85% | -1.87% | 21.19% | -11.61% |
| BlackRock Science | -3.43% | 1.54% | 2.95% | 11.59% | 29.54% | 10.67% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Virtus Investment | -6.81% | 30.93% | 17.49% | 81.97% | 446.11% | 1,792.19% |
| BlackRock Science | 18.90% | 37.02% | -18.34% | 10.67% | 10.67% | 10.67% |
News Based Sentiment: Virtus Investment vs BlackRock Science
Virtus Investment
News based Sentiment: POSITIVE
Virtus Investment Partners reported modest growth in both revenue and net income for the first quarter of 2024, alongside an increase in assets under management. This, combined with their continued commitment to consistent dividend distributions from both the DNP Select Income Fund and the Virtus InfraCap U.S. Preferred Stock ETF, paints a picture of stable, reliable performance.
BlackRock Science
News based Sentiment: NEGATIVE
The decrease in distributions coupled with concerns about the fund's reliance on Return of Capital distributions creates a negative narrative for BSTZ investors. While the reaffirmation of the investment strategy provides some stability, the distribution issues are a significant concern.
Performance & Financial Health Analysis: Virtus Investment vs BlackRock Science
| Metric | VRTS | BSTZ |
|---|---|---|
| Market Information | ||
| Market Cap | $1.15B | $1.57B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 44,090 | 267,050 |
| 90 Day Avg. Volume | 45,910 | 261,050 |
| Last Close | $183.97 | $22.23 |
| 52 Week Range | $142.18 - $252.82 | $15.22 - $23.12 |
| % from 52W High | -27.23% | -3.85% |
| All-Time High | $338.80 (Oct 25, 2021) | $43.76 (Nov 08, 2021) |
| % from All-Time High | -45.70% | -49.20% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.02% | N/A |
| Quarterly Earnings Growth | -0.04% | N/A |
| Financial Health | ||
| Profit Margin (TTM) | 0.13% | 0.00% |
| Operating Margin (TTM) | 0.17% | 0.00% |
| Return on Equity (TTM) | 0.14% | 0.16% |
| Debt to Equity (MRQ) | 29.88 | 0.00 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $129.32 | N/A |
| Cash per Share (MRQ) | $31.67 | N/A |
| Operating Cash Flow (TTM) | $32.50M | $282.29M |
| Levered Free Cash Flow (TTM) | $97.41M | $272.28M |
| Dividends | ||
| Last 12-Month Dividend Yield | 4.97% | N/A |
| Last 12-Month Dividend | $8.65 | N/A |
Valuation & Enterprise Metrics Analysis: Virtus Investment vs BlackRock Science
| Metric | VRTS | BSTZ |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 9.91 | 3.67 |
| Forward P/E | 5.54 | N/A |
| PEG Ratio | 5.54 | N/A |
| Price to Sales (TTM) | 1.28 | 5.72 |
| Price to Book (MRQ) | 1.29 | N/A |
| Market Capitalization | ||
| Market Capitalization | $1.15B | $1.57B |
| Enterprise Value | $1.36B | $0 |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.51 | 0.00 |
| Enterprise to EBITDA | 5.47 | N/A |
| Risk & Other Metrics | ||
| Beta | 1.47 | N/A |
| Book Value per Share (MRQ) | $129.32 | N/A |
Financial Statements Comparison: Virtus Investment vs BlackRock Science
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | VRTS | BSTZ |
|---|---|---|
| Revenue/Sales | $216.85M | N/A |
| Cost of Goods Sold | $109.09M | N/A |
| Gross Profit | $107.76M | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $36.60M | N/A |
| EBITDA | $104.28M | N/A |
| Pre-Tax Income | $40.40M | N/A |
| Income Tax | $12.35M | N/A |
| Net Income (Profit) | $28.05M | N/A |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | VRTS | BSTZ |
|---|---|---|
| Cash & Equivalents | $399.58M | $100,375 |
| Total Current Assets | $517.52M | N/A |
| Total Current Liabilities | $207.53M | N/A |
| Long-Term Debt | $2.47B | N/A |
| Total Shareholders Equity | $1.01B | $1.53B |
| Retained Earnings | $268.22M | $578.45M |
| Property, Plant & Equipment | $57.13M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | VRTS | BSTZ |
|---|---|---|
| Operating Cash Flow | $-140.81M | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | $-104.73M | N/A |
| Debt Repayment | $-53.87M | N/A |
| Common Stock Repurchase | $-12.50M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | VRTS | BSTZ |
|---|---|---|
| Shares Short | 84,659 | 71,226 |
| Short Ratio | 1.58 | 0.29 |
| Short % of Float | 0.02% | 0.00% |
| Average Daily Volume (10 Day) | 44,090 | 267,050 |
| Average Daily Volume (90 Day) | 45,910 | 261,050 |
| Shares Outstanding | 6.97M | 72.31M |
| Float Shares | 6.46M | N/A |
| % Held by Insiders | 0.06% | 0.00% |
| % Held by Institutions | 0.84% | 0.28% |
Dividend Analysis & Yield Comparison: Virtus Investment vs BlackRock Science
| Metric | VRTS | BSTZ |
|---|---|---|
| Last 12-Month Dividend | $8.65 | N/A |
| Last 12-Month Dividend Yield | 4.97% | N/A |
| 3-Year Avg Annual Dividend | $7.48 | N/A |
| 3-Year Avg Dividend Yield | 0.94% | N/A |
| 3-Year Total Dividends | $22.45 | N/A |
| Ex-Dividend Date | Apr 30, 2025 | N/A |